期刊文献+

肝脏干细胞恶性转化的研究进展 被引量:4

Progress on malignant transformation of hepatic stem cells
原文传递
导出
摘要 越来越多的研究认为,包括肝癌在内的许多恶性肿瘤是干细胞来源的疾病,并且肝癌的发生、耐药、转移及复发与肿瘤内被称作肿瘤干细胞的一小群细胞密切相关。虽然对肝癌及肝癌干细胞的来源仍有争议,但通过近十多年的大量研究,很多学者认为肝癌及肝癌干细胞很有可能是由正常肝脏干细胞在各种致癌因素下发生恶性转化而来的。本文就正常肝脏干细胞恶性转化方面的相关研究进展进行综述。 Compelling evidences have shown that various types of cancer, including hepatocellular carcinoma, are originated from stem cells. The occurrence, chemoresistance, metastasis and recurrence of hepatocellular carci- noma are associated with a small population of cells called "cancer stem cells". Although the origin of hepatocellu- lar carcinoma and hepatic cancer stem cells remain controversial after a decade of intensive investigation, increasing scholars tend to believe that hepatocellular carcinoma and hepatic cancer stem cells can derive from malignant trans- formation of hepatic stem ceils being exposed to various kinds of carcinogens. In this review, we mainly focus on the recent progress on malignant transformation of hepatic stem ceils .
出处 《国际外科学杂志》 2013年第1期42-46,共5页 International Journal of Surgery
基金 国家自然科学基金重点项目(No.81030010)
关键词 肝肿瘤 干细胞 细胞转化 肿瘤 Liver neoplasms Stem cells Cell transformation, neoplastic
  • 相关文献

参考文献1

二级参考文献6

  • 1周旭,易继林,郭悦青,刘恩宇,李兴睿.PTEN与hTERT在肝细胞肝癌中的表达及其相关性研究[J].中华实验外科杂志,2005,22(1):55-57. 被引量:17
  • 2Maggioni M,Coggi G,Cassani B,et al.Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.Hepatology,2000,32:942-946.
  • 3Ng IO,Guan XY,Pooh RT,et al.Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis.J Pathol,2003,199:345-353.
  • 4Chen CF,Yeh SH,Chen DS,et al.Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11.Genes Chromosomes Cancer,2005,44:320-328.
  • 5Isfort RJ,Cody DB,Deersen C J,et al.The tetratricopoptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene.Oncogene,1997,15:1797-1803.
  • 6赵爱志,窦科峰,李开宗,付由池.肝细胞肝癌中p53、ras基因与血管内皮生长因子表达的关系[J].中华实验外科杂志,2000,17(5):424-425. 被引量:3

共引文献3

同被引文献43

  • 1王志明,周乐杜,吕新生,游森,李劲东.原发性肝癌治疗方法的选择:附265例报告[J].中国普通外科杂志,2004,13(12):908-911. 被引量:8
  • 2Rountree CB,Mishra L,Willenbring H. Stem cells in liver diseases and cancer;recent advances on the path to new therapies[J].{H}HEPATOLOGY,2012.298-306.
  • 3Ji J,Wang XW. Clinical implications of cancer stem cell biology in hepatocellular carcinoma[J].{H}Seminars in Oncology,2012.461-472.
  • 4Visvader JE,Lindeman GJ. Cancer stem cells in solid tumours;accumulating evidence and unresolved questions[J].{H}Nature Reviews Cancer,2008.755-768.
  • 5Chiba T,Kita K,Zheng YW. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties[J].{H}HEPATOLOGY,2006.240-251.
  • 6Zen Y,Fujii T,Yoshikawa S. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma[J].{H}AMERICAN JOURNAL OF PATHOLOGY,2007.1750-1762.
  • 7Ma S. Biology and clinical implications of CD133(+)liver cancer stem cells[J].{H}Experimental Cell Research,2013.126-132.
  • 8Kohga K,Tatsumi T,Takehara T. Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma[J].{H}Journal of Hepatology,2010.872-879.
  • 9Tang KH,Ma S,Lee TK. CD133(+)liver tumor-initiating cells promote tumor angiogenesis,growth,and self-renewal through neurotensin/interleukin-8/CXCL1 signaling[J].{H}HEPATOLOGY,2012.807-820.
  • 10Yamashita T,Ji J,Budhu A. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features[J].{H}GASTROENTEROLOGY,2009.1012-1024.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部